ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

PI

Portuguese Institute of Oncology of Lisbon at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Portuguese Institute of Oncology of Lisbon takes part in 4 sessions at ESMO 2026 in Madrid. Its work spans melanoma, esophageal cancer and head and neck cancer. It examines real-world immunotherapy dosing in melanoma, outcomes and side effects of adjuvant nivolumab for esophageal cancer, and smoking as a risk factor in HPV-positive throat cancer.

OrganizationESMO 2026 Attendance
PI
Portuguese Institute of Oncology of Lisbon
Lisbon, Portugal
Cancer centre & hospital
Public cancer hospital in Lisbon, Portugal.
Poster
Fri Oct 23
13:00–15:00
Poster
Sun Oct 25
12:00–12:45
Adjuvant nivolumab in locally advanced esophageal cancer – real-world outcomes, safety, and time-toxicity
Sunday Poster Display session 3
Gastrointestinal cancers
Abstract
Mon Oct 26
11:27–11:37
Invited Discussant 4208O and 42090
Proffered paper: NETs and endocrine tumours
Sarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Portuguese Institute of Oncology of Lisbon

Tell us what you sell and we’ll find the people at Portuguese Institute of Oncology of Lisbon most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction